Topic Review
3D-Printed Tumour Models
Three-dimensional (3D) printing technology has revolutionized our perception of how advanced technologies contribute to medical education and clinical practice by augmenting the current visualization tools or standard diagnostic or planning approaches used in the different fields of medicine. 3D printed personalized models serve as a valuable tool in improving understanding of complex anatomy and pathology, in particular, when assessing tumours, since 3D printed physical models provide direct visualization of the tumour in relation to surrounding structures. 
  • 236
  • 21 Feb 2023
Topic Review
3D-Printing Techniques for Surgical Planning in Orthopedic Surgery
Orthopedic oncology has begun to use three-dimensional-printing technology, which is expected to improve the accuracy of osteotomies, ensure a safe margin, and facilitate precise surgery. However, several difficulties should be considered.
  • 394
  • 18 Apr 2023
Topic Review
3DP Medicines and Medical Devices
Novel additive manufacturing (AM) techniques and particularly 3D printing (3DP) have achieved a decade of success in pharmaceutical and biomedical fields. Highly innovative personalized therapeutical solutions may be designed and manufactured through a layer-by-layer approach starting from a digital model realized according to the needs of a specific patient or a patient group. The combination of patient-tailored drug dose, dosage, or diagnostic form (shape and size) and drug release adjustment has the potential to ensure the optimal patient therapy. This document provides an overview on different 3DP techniques to produce personalized medicines and medical devices, highlighting, for each method, the critical printing process parameters, the main starting materials, as well as advantages and limitations.
  • 1.3K
  • 17 May 2022
Topic Review
4D Printing Technology
4D printing (4DP) is an evolution of 3DP where additive manufacturing printing techniques are employed. In other words, adapting 3DP processes for 4DP of shape memory polymers (SMPs) or smart materials requires minor adjustments. In order to produce the desired shape-changing materials as per estimation or for optimal application, an air circulation system may be incorporated into 3DP’s traditional fused deposition method (FDM) technology. This would cool the SMP below its Tg and, after these small alterations, previous 3DP methods such as stereolithography apparatus (SLA), digital laser writing and inkjet printing can also be employed.
  • 446
  • 05 Jan 2023
Topic Review
4D-Flow Imaging in Aortic Valve Disease
The development of abnormal blood flow has been demonstrated to be due to a variety of pathological causes, such as atherosclerotic plaque or valvular disease. Traditionally, cardiovascular magnetic resonance imaging (MRI) has provided high-quality imaging of the heart with its surrounding structures. 4D-flow imaging is an advanced cardiac MR imaging technique that allows fluid hemodynamics to be measured non-invasively in patients. As a growing field in radiology, its adaptation and clinical use remain underutilized. 
  • 312
  • 21 Jun 2023
Topic Review
5-10-Methylenetetrahydrofolate Reductase
The 5-10-methylenetetrahydrofolate reductase (MTHFR) enzyme is vital for cellular homeostasis due to its key functions in the one-carbon cycle, which include methionine and folate metabolism, and protein, DNA, and RNA synthesis. 
  • 565
  • 14 Feb 2022
Topic Review
5-ALA Metabolic Pathway
5-Aminolevulinic acid (5-ALA) is a natural amino acid and a precursor of heme and chlorophyll. Exogenously administered 5-ALA is metabolized into protoporphyrin IX (PpIX). PpIX accumulates in cancer cells because of the low activity of ferrochelatase, an enzyme that metabolizes PpIX to heme. High expression of 5-ALA influx transporters, such as peptide transporters 1/2, in cancer cells also enhances PpIX production. Because PpIX radiates red fluorescence when excited with blue/violet light, 5-ALA has been used for the visualization of various tumors. 
  • 669
  • 22 Jun 2022
Topic Review
5-Aminolevulinic Acid in Gliomas
5-aminolevulinic acid (5-ALA) is a porphyrin precursor in the heme synthesis pathway. When supplied exogenously, certain cancers consume 5-ALA and convert it to the fluorogenic metabolite protoporphyrin IX (PpIX), causing tumor-specific tissue fluorescence. Preoperative administration of 5-ALA is used to aid neurosurgical resection of high-grade gliomas such as glioblastoma, allowing for increased extent of resection and progression free survival for these patients. Targeting the heme synthesis pathway and understanding its dysregulation in malignant tissues could aid the development of adjunct therapies to increase intraoperative fluorescence after 5-ALA treatment
  • 550
  • 14 Apr 2021
Topic Review
5-Aminolevulinic Acid in Photodynamic Therapy
5-Aminolevulinic acid (ALA) is a naturally occurring amino acid synthesized in all nucleated mammalian cells. As a porphyrin precursor, ALA is metabolized in the heme biosynthetic pathway to produce protoporphyrin IX (PpIX), a fluorophore and photosensitizing agent. ALA administered exogenously bypasses the rate-limit step in the pathway, resulting in PpIX accumulation in tumor tissues. Such tumor-selective PpIX disposition following ALA administration has been exploited for tumor fluorescence diagnosis and photodynamic therapy (PDT) with much success. Five ALA-based drugs have now received worldwide approval and are being used for managing very common human (pre)cancerous diseases such as actinic keratosis and basal cell carcinoma or guiding the surgery of bladder cancer and high-grade gliomas, making it the most successful drug discovery and development endeavor in PDT and photodiagnosis. 
  • 425
  • 04 May 2023
Topic Review
5-Aminolevulinic Acid Photodynamic Therapy in Cancer Treatment
5-aminolevulinic acid-photodynamic therapy (5-ALA-PDT) is a therapeutic option for a variety of cutaneous and internal malignancies. PDT uses a photosensitizer that, activated by light in the presence of molecule oxygen, forms ROS, which are responsible for the apoptotic activity of the malignant tissues. 5-ALA is usually used as an endogenous pro-photosensitizer because it is converted to Protoporphyrin IX (PpIX), which enters into the process of heme synthesis and contextually becomes a photosensitizer, radiating a red fluorescent light. PDT has the benefit of being administered before or after chemotherapy, radiation, or surgery, without impairing the efficacy of these treatment techniques. Furthermore, sensitivity to PDT is unaffected by the negative effects of chemotherapy or radiation. 
  • 493
  • 30 May 2023
  • Page
  • of
  • 1352
Video Production Service